Literature DB >> 22871841

Using flow cytometry to compare the dynamics of photoreceptor outer segment phagocytosis in iPS-derived RPE cells.

Peter D Westenskow1, Stacey K Moreno, Tim U Krohne, Toshihide Kurihara, Saiyong Zhu, Zhen-Ning Zhang, Tongbiao Zhao, Yang Xu, Sheng Ding, Martin Friedlander.   

Abstract

PURPOSE: Retinal pigment epithelium (RPE) autologous grafts can be readily derived from induced pluripotent stem (iPS) cells. It is critical to stringently characterize iPS-RPE using standardized and quantifiable methods to be confident that they are safe and adequate replacements for diseased RPE before utilizing them in clinical settings. One important and required function is that the iPS-RPE phagocytose photoreceptor outer segments (POS).
METHODS: We developed a flow cytometry-based assay to monitor binding and internalization of FITC labeled POS by ARPE-19, human fetal RPE (hfRPE), and two types of iPS-RPE. Expression and density of α(v)β₅ integrin, CD36, and MerTK receptors, which are required for phagocytosis, were compared.
RESULTS: Trypsinization of treated RPE cells results in the release of bound POS. The number of freed POS, the percentage of cells that internalized POS, the brightness of the FITC signal from the cells, and the surface density of the phagocytosis receptors on single RPE cells were measured using flow cytometry. These assays reveal that receptor density is dynamic during differentiation and this can affect the binding and internalization dynamics of the RPE cells. Highly differentiated iPS-RPE phagocytose POS more efficiently than hfRPE.
CONCLUSIONS: Caution should be exercised to not use RPE grafts until demonstrating that they are fully functional. The density of the phagocytosis receptors is dynamic and may be used as a predictor for how well the iPS-RPE cells will function in vivo. The phagocytosis dynamics observed between iPS-RPE and primary RPE is very encouraging and adds to mounting evidence that iPS-RPE may be a viable replacement for dysfunctional or dying RPE in human patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22871841      PMCID: PMC3444211          DOI: 10.1167/iovs.12-9721

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  33 in total

1.  Generation of retinal pigment epithelial cells from small molecules and OCT4 reprogrammed human induced pluripotent stem cells.

Authors:  Tim U Krohne; Peter D Westenskow; Toshihide Kurihara; David F Friedlander; Mandy Lehmann; Alison L Dorsey; Wenlin Li; Saiyong Zhu; Andrew Schultz; Junhua Wang; Gary Siuzdak; Sheng Ding; Martin Friedlander
Journal:  Stem Cells Transl Med       Date:  2012-02       Impact factor: 6.940

2.  Immunogenicity of induced pluripotent stem cells.

Authors:  Tongbiao Zhao; Zhen-Ning Zhang; Zhili Rong; Yang Xu
Journal:  Nature       Date:  2011-05-13       Impact factor: 49.962

3.  Reprogramming of human primary somatic cells by OCT4 and chemical compounds.

Authors:  Saiyong Zhu; Wenlin Li; Hongyan Zhou; Wanguo Wei; Rajesh Ambasudhan; Tongxiang Lin; Janghwan Kim; Kang Zhang; Sheng Ding
Journal:  Cell Stem Cell       Date:  2010-12-03       Impact factor: 24.633

4.  Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat.

Authors:  P M D'Cruz; D Yasumura; J Weir; M T Matthes; H Abderrahim; M M LaVail; D Vollrath
Journal:  Hum Mol Genet       Date:  2000-03-01       Impact factor: 6.150

5.  Causes and prevalence of visual impairment among adults in the United States.

Authors:  Nathan Congdon; Benita O'Colmain; Caroline C W Klaver; Ronald Klein; Beatriz Muñoz; David S Friedman; John Kempen; Hugh R Taylor; Paul Mitchell
Journal:  Arch Ophthalmol       Date:  2004-04

6.  Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat.

Authors:  Amanda-Jayne Carr; Anthony A Vugler; Sherry T Hikita; Jean M Lawrence; Carlos Gias; Li Li Chen; David E Buchholz; Ahmad Ahmado; Ma'ayan Semo; Matthew J K Smart; Shazeen Hasan; Lyndon da Cruz; Lincoln V Johnson; Dennis O Clegg; Pete J Coffey
Journal:  PLoS One       Date:  2009-12-03       Impact factor: 3.240

7.  Focal adhesion kinase signaling promotes phagocytosis of integrin-bound photoreceptors.

Authors:  Silvia C Finnemann
Journal:  EMBO J       Date:  2003-08-15       Impact factor: 11.598

8.  Modeling early retinal development with human embryonic and induced pluripotent stem cells.

Authors:  Jason S Meyer; Rebecca L Shearer; Elizabeth E Capowski; Lynda S Wright; Kyle A Wallace; Erin L McMillan; Su-Chun Zhang; David M Gamm
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-25       Impact factor: 11.205

9.  Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells.

Authors:  Maria Idelson; Ruslana Alper; Alexey Obolensky; Etti Ben-Shushan; Itzhak Hemo; Nurit Yachimovich-Cohen; Hanita Khaner; Yoav Smith; Ofer Wiser; Michal Gropp; Malkiel A Cohen; Sharona Even-Ram; Yael Berman-Zaken; Limor Matzrafi; Gideon Rechavi; Eyal Banin; Benjamin Reubinoff
Journal:  Cell Stem Cell       Date:  2009-10-02       Impact factor: 24.633

10.  Differential roles of CD36 and alphavbeta5 integrin in photoreceptor phagocytosis by the retinal pigment epithelium.

Authors:  S C Finnemann; R L Silverstein
Journal:  J Exp Med       Date:  2001-11-05       Impact factor: 14.307

View more
  25 in total

1.  Small-molecule-directed, efficient generation of retinal pigment epithelium from human pluripotent stem cells.

Authors:  Julien Maruotti; Srinivas R Sripathi; Kapil Bharti; John Fuller; Karl J Wahlin; Vinod Ranganathan; Valentin M Sluch; Cynthia A Berlinicke; Janine Davis; Catherine Kim; Lijun Zhao; Jun Wan; Jiang Qian; Barbara Corneo; Sally Temple; Ramin Dubey; Bogdan Z Olenyuk; Imran Bhutto; Gerard A Lutty; Donald J Zack
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-12       Impact factor: 11.205

2.  Enhancing RPE Cell-Based Therapy Outcomes for AMD: The Role of Bruch's Membrane.

Authors:  Janosch P Heller; Keith R Martin
Journal:  Transl Vis Sci Technol       Date:  2014-07-03       Impact factor: 3.283

3.  Performing subretinal injections in rodents to deliver retinal pigment epithelium cells in suspension.

Authors:  Peter D Westenskow; Toshihide Kurihara; Stephen Bravo; Daniel Feitelberg; Zack A Sedillo; Edith Aguilar; Martin Friedlander
Journal:  J Vis Exp       Date:  2015-01-23       Impact factor: 1.355

Review 4.  RNA-Seq: Improving Our Understanding of Retinal Biology and Disease.

Authors:  Michael H Farkas; Elizabeth D Au; Maria E Sousa; Eric A Pierce
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-26       Impact factor: 6.915

5.  Appropriately differentiated ARPE-19 cells regain phenotype and gene expression profiles similar to those of native RPE cells.

Authors:  William Samuel; Cynthia Jaworski; Olga A Postnikova; R Krishnan Kutty; Todd Duncan; Li Xuan Tan; Eugenia Poliakov; Aparna Lakkaraju; T Michael Redmond
Journal:  Mol Vis       Date:  2017-03-05       Impact factor: 2.367

6.  Assessing Retinal Microglial Phagocytic Function In Vivo Using a Flow Cytometry-based Assay.

Authors:  Salome Murinello; Stacey K Moreno; Matthew S Macauley; Susumu Sakimoto; Peter D Westenskow; Martin Friedlander
Journal:  J Vis Exp       Date:  2016-10-18       Impact factor: 1.355

7.  Nicotinamide: a novel treatment for age-related macular degeneration?

Authors:  Peter D Westenskow
Journal:  Stem Cell Investig       Date:  2017-10-27

Review 8.  Understanding photoreceptor outer segment phagocytosis: use and utility of RPE cells in culture.

Authors:  Francesca Mazzoni; Hussein Safa; Silvia C Finnemann
Journal:  Exp Eye Res       Date:  2014-04-26       Impact factor: 3.467

9.  Efficient derivation of retinal pigment epithelium cells from stem cells.

Authors:  Peter Westenskow; Zack Sedillo; Ashley Barnett; Martin Friedlander
Journal:  J Vis Exp       Date:  2015-03-08       Impact factor: 1.355

Review 10.  Translating induced pluripotent stem cells from bench to bedside: application to retinal diseases.

Authors:  Alona O Cramer; Robert E MacLaren
Journal:  Curr Gene Ther       Date:  2013-04       Impact factor: 4.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.